Approval · Notice of Compliance 2173 · 2001
FRAGMIN: Notice of Compliance 2173
Issued February 15, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2173
- Date
- February 15, 2001
- Company
- Pharmacia Canada Inc.Baie D'Urfe, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anticoagulant, antithrombic agent
Products in this notice
Medicinal ingredients
- DALTEPARIN SODIUM 10,000 UNIT per ML
- DALTEPARIN SODIUM 25,000 UNIT per ML
- DALTEPARIN SODIUM 2,500 UNIT per 0.2ML
- DALTEPARIN SODIUM 5,000 UNIT per 0.2ML